Association Updates: Cranz Returns To Lead BAH, Plus News From WSMI, PAGB And ASMI
Executive Summary
Former AESGP head Dr Hubertus Cranz steps in to lead BAH; WSMI calls on WHO to back self-care; PAGB appoints Riddalls to regulatory role; and ASMI changes its name.
You may also be interested in...
OTC Medical Device Bottleneck Will Have 'Serious Implications' For German Industry, Says BAH’s Dr Cranz
In an exclusive interview with HBW Insight, the German Medicines Manufacturers´ Association’s (BAH’s) new director general Dr Hubertus Cranz warns of a potentially costly bottleneck forming as German manufacturers scramble to re-certify their self-care medical devices before the May 2020 European Union's new Medical Device Regulations deadline. Dr Cranz also explains how BAH is supporting the country's community pharmacists to help German consumers to self-care safely and responsibly.
People Round-Up: Appointments At Afipa, J&J, Stada, WSMI, And Karo
J&J Consumer has a new chairman, Stada UK gets a permanent head, and Karo names its next CEO. On the association front, France's Afipa and the WSMI elect new leaders.
People Round-Up: Appointments at Angelini, Polpharma, GSK, EMA, Holland & Barrett and Blackmores
Angelini, Holland & Barrett and Blackmores have new CEOs, while GSK, Polpharma and the EMA have made executive appointments.